A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems

针对美国创伤护理系统中接受治疗的急性住院损伤幸存者的创伤后应激障碍 (PTSD) 和合并症的最佳阶梯式护理干预的以部署为重点的务实试验

基本信息

  • 批准号:
    10506526
  • 负责人:
  • 金额:
    $ 79.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Life-threatening traumatic exposures requiring presentation to acute care medical settings are endemic in the US in the era of the COVID-19 pandemic, firearm proliferation, and extreme weather events, and constitute both a substantial source of individual suffering and a significant public health burden. Each year in the US, over 30 million individuals present to acute care medical settings after injury, and approximately 2.5 million individuals are so severely injured that they require inpatient hospital admissions. The overarching goal of the Trauma Survivors Outcomes and Support (TSOS) R01 investigation is to advance the sustainable delivery of high quality trauma center mental health screening, intervention and referral procedures for diverse injury survivors. Over the past two decades, the TSOS study team that includes research scientists, trauma surgical policymakers, patients, and frontline clinicians has established a track record of using evidence derived from NIH pragmatic trials to directly target American College of Surgeons Committee on Trauma (College) regulatory policy. The TSOS R01 investigation will refine and test optimal stepped care intervention strategies for diverse injury survivors presenting to acute care medical settings with PTSD and associated comorbidity. This single trauma center site pragmatic trial investigation will individually randomize 424 patients (212 intervention and 212 control) to a brief stepped care intervention versus College required screening and referral control conditions. The stepped care intervention consists of proactive care management, as well as medications and psychotherapy elements targeting PTSD and comorbidity. Blinded follow-up interviews at 3-, 6-, and 12-months post-injury will assess the symptoms of PTSD and related comorbidity for all patients. The emergency department health information exchange will be used to capture population-level automated emergency department/inpatient utilization data for the intent-to-treat sample. The R01 aims to test the primary hypotheses that intervention patients will demonstrate significant reductions in PTSD symptoms and emergency department/inpatient utilization when compared to control patients. The investigation will also explore mediators and moderators of intervention treatment effects that directly address actionable national trauma center quality improvements. A mixed method Rapid Assessment Procedure-Informed Clinical Ethnography implementation process assessment will facilitate the integration of study results into national College policy requirements, guidelines, and verification criteria. A national trauma center survey will elucidate the progression of PTSD and comorbidity screening, intervention and referral for all US level I and II trauma centers. An end-of-study College policy summit will harness pragmatic trial data to inform the capacity for US trauma centers to implement high quality acute care medical mental health services for diverse patient populations.
摘要 需要紧急护理医疗环境的危及生命的创伤暴露在美国是一种地方病, 美国在COVID-19大流行、枪支扩散和极端天气事件的时代, 这既是个人痛苦的主要来源,也是重大的公共卫生负担。每年在美国, 超过3000万人在受伤后进入急诊医疗机构, 有些人受伤严重,需要住院治疗。的首要目标 创伤幸存者结局和支持(TSOS)R 01调查旨在促进 高质量创伤中心心理健康筛查、干预和转诊程序,用于各种伤害 幸存者在过去的二十年里,TSOS研究团队,包括研究科学家,创伤外科医生, 政策制定者、患者和一线临床医生已经建立了使用来自以下方面的证据的跟踪记录: NIH务实试验直接针对美国外科医生学会创伤委员会(学院) 监管政策。TSOS R 01调查将完善和测试最佳的阶梯式护理干预策略 对于不同的创伤幸存者提出的急性护理医疗设置与创伤后应激障碍和相关的合并症。 这一单一创伤中心现场务实的试验研究将单独随机化424例患者(212 干预和212对照),以简短的分步护理干预与大学要求的筛选, 转介控制条件分级护理干预包括积极主动的护理管理,以及 针对创伤后应激障碍和并发症的药物和心理治疗元素。3点进行盲法后续采访, 伤后6个月和12个月将评估所有患者的PTSD症状和相关合并症。的 急诊科健康信息交换将用于获取人口水平的自动化 意向治疗样本的急诊科/住院患者使用数据。R 01旨在测试主要的 假设干预患者将表现出PTSD症状的显着减少, 与对照组患者相比,急诊科/住院患者的利用率。调查还将 探索直接解决可采取行动的国家干预治疗效果的中介者和调节者 提高创伤中心的质量一种混合方法快速评估程序-通知临床 民族志实施过程评估将有助于将研究结果纳入国家 学院政策要求,指导方针和验证标准。国家创伤中心的调查将阐明 所有美国I级和II级创伤的PTSD和合并症筛查、干预和转诊进展 中心.一个研究结束学院政策峰会将利用务实的试验数据,以告知美国的能力 创伤中心为不同患者提供高质量的急性护理医疗心理健康服务 人口。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EILEEN M BULGER其他文献

EILEEN M BULGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EILEEN M BULGER', 18)}}的其他基金

Pacific Northwest Clinical Center for the NHLBI PETAL Network
NHLBI PETAL 网络西北太平洋临床中心
  • 批准号:
    8874280
  • 财政年份:
    2014
  • 资助金额:
    $ 79.02万
  • 项目类别:
Pacific Northwest Clinical Center for the NHLBI PETAL Network
NHLBI PETAL 网络西北太平洋临床中心
  • 批准号:
    9053366
  • 财政年份:
    2014
  • 资助金额:
    $ 79.02万
  • 项目类别:
Pacific Northwest Clinical Center for the NHLBI PETAL Network
NHLBI PETAL 网络西北太平洋临床中心
  • 批准号:
    8705819
  • 财政年份:
    2014
  • 资助金额:
    $ 79.02万
  • 项目类别:
Hypertonic Modulation of Inflammation following Injury
损伤后炎症的高渗调节
  • 批准号:
    7442250
  • 财政年份:
    2007
  • 资助金额:
    $ 79.02万
  • 项目类别:
Hypertonic Modulation of Inflammation following Injury
损伤后炎症的高渗调节
  • 批准号:
    7857900
  • 财政年份:
    2007
  • 资助金额:
    $ 79.02万
  • 项目类别:
Hypertonic Modulation of Inflammation following Injury
损伤后炎症的高渗调节
  • 批准号:
    7625093
  • 财政年份:
    2007
  • 资助金额:
    $ 79.02万
  • 项目类别:
Hypertonic Modulation of Inflammation following Injury
损伤后炎症的高渗调节
  • 批准号:
    7194735
  • 财政年份:
    2007
  • 资助金额:
    $ 79.02万
  • 项目类别:
The Effect of Hypertonic Resuscitation for Blunt Trauma
高渗复苏治疗钝挫伤的效果
  • 批准号:
    6595669
  • 财政年份:
    2003
  • 资助金额:
    $ 79.02万
  • 项目类别:
The Effect of Hypertonic Resuscitation for Blunt Trauma
高渗复苏治疗钝挫伤的效果
  • 批准号:
    6879925
  • 财政年份:
    2003
  • 资助金额:
    $ 79.02万
  • 项目类别:
The Effect of Hypertonic Resuscitation for Blunt Trauma
高渗复苏治疗钝挫伤的效果
  • 批准号:
    6746971
  • 财政年份:
    2003
  • 资助金额:
    $ 79.02万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 79.02万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了